The score's developers also suggest that current guidelines for stroke prevention may not be sufficient for individuals at higher genomic risk for the condition.
Neurosurgeon Christopher Kellner is developing a test for aneurysm detection and leading an industry-funded effort to profile blood clots from stroke patients.
Within the "Big Three" conditions, misdiagnoses related to stroke, sepsis, and lung cancer accounted for the most high-severity diagnostic error cases.
The guidelines provide recommendations for what CYP2C9 variant alleles should be included in clinical pharmacogenomic tests assessing that gene.
Researchers reported that elevated high-sensitivity troponin I is strongly associated with increased risk of cardiovascular disease in some populations.
The firm is using a microarray-based platform as part of a laboratory-based test to diagnose different types of stroke from blood samples.
Galaxy has licensed IP from Proteome Sciences for the development of a test for the diagnosis and timing of stroke onset to help inform treatment decisions.
A new study suggests binding proteins that target glucose or asparagine can be used in combination with cytolysin A-based nanopores to electrically detect the metabolites.
The mobile approach enables stroke patients to be assessed within the three-hour window for stroke treatment.
A new study has demonstrated that adding analysis of a specific type of triglyceride may improve the ability to identify individuals at risk for heart attack and stroke.